000 | 01968 a2200529 4500 | ||
---|---|---|---|
005 | 20250513223756.0 | ||
264 | 0 | _c20001115 | |
008 | 200011s 0 0 eng d | ||
022 | _a0003-9950 | ||
024 | 7 |
_a10.1001/archopht.118.11.1489 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKunert, K S | |
245 | 0 | 0 |
_aAnalysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. _h[electronic resource] |
260 |
_bArchives of ophthalmology (Chicago, Ill. : 1960) _cNov 2000 |
||
300 |
_a1489-96 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Topical |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntigens, CD _ximmunology |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aConjunctiva _ximmunology |
650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
650 | 0 | 4 |
_aDry Eye Syndromes _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
650 | 0 | 4 |
_aHLA-DR Antigens _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunophenotyping |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
650 | 0 | 4 |
_aLymphocytes _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOphthalmic Solutions _xtherapeutic use |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
650 | 0 | 4 |
_aT-Lymphocytes, Helper-Inducer _ximmunology |
700 | 1 | _aTisdale, A S | |
700 | 1 | _aStern, M E | |
700 | 1 | _aSmith, J A | |
700 | 1 | _aGipson, I K | |
773 | 0 |
_tArchives of ophthalmology (Chicago, Ill. : 1960) _gvol. 118 _gno. 11 _gp. 1489-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archopht.118.11.1489 _zAvailable from publisher's website |
999 |
_c11016565 _d11016565 |